Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
|---|---|---|---|
| Operating cash flow (direct method) | |||
| Cash income from operating activities | -1 | ||
| Other cash income from operating activities | ---- | ---- | ---1 |
| Cash paid | -59.45%-1.58M | -4.82%-993.2K | -947.55K |
| Payments to suppliers for goods and services | -59.45%-1.58M | -4.82%-993.2K | ---947.55K |
| Direct interest received | -8.76%97.64K | 61.44%107.02K | --66.29K |
| Operating cash flow | -67.69%-1.49M | -0.56%-886.19K | ---881.27K |
| Investing cash flow | |||
| Cash flow from continuing investing activities | 39.67%-1.58M | -281.38%-2.62M | -687.81K |
| Capital expenditure reported | 46.07%-1.58M | -225.04%-2.93M | ---902.81K |
| Net other investing changes | ---- | 44.82%311.36K | --215K |
| Cash from discontinued investing activities | |||
| Investing cash flow | 39.67%-1.58M | -281.38%-2.62M | ---687.81K |
| Financing cash flow | |||
| Cash flow from continuing financing activities | -31.36%2.25M | 1.56%3.28M | 3.23M |
| Net common stock issuance | -31.36%2.25M | 1.56%3.28M | --3.23M |
| Cash from discontinued financing activities | |||
| Financing cash flow | -31.36%2.25M | 1.56%3.28M | --3.23M |
| Net cash flow | |||
| Beginning cash position | -9.34%2.23M | 207.30%2.46M | --800.75K |
| Current changes in cash | -255.67%-817.51K | -113.85%-229.85K | --1.66M |
| Effect of exchange rate changes | ---7.97K | ---- | ---- |
| End cash Position | -37.00%1.41M | -9.34%2.23M | --2.46M |
| Free cash from | 19.69%-3.07M | -114.16%-3.82M | ---1.78M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |